Researchers report on a multinational, early phase clinical trial evaluating a new targeted therapy for patients with metastatic or unresectable non-small cell lung cancer who have a specific genetic mutation: EGFR Ex20Ins.
source https://www.sciencedaily.com/releases/2021/08/210803105526.htm
Wednesday, 4 August 2021
Related Posts
New insights into the relationship between how we feel and our views on agingA new study finds that the disconnect between how old we feel and how … Read More
Turning diapers into sticky notes: Using chemical recycling to prevent millions of tons of wasteEvery year, 3.5 million metric tons of sodden diapers end up in landfi… Read More
Breakthrough research examines the effects introduced animals had on Madagascar’s extinct megafaunaMadagascar is renowned for its unique and varied biodiversity, which s… Read More
Genomic secrets of deep-sea tubewormResearchers have decoded the chromosomal-level genome of a deep-sea gu… Read More
Bird’s-eye view could be key to navigating without GPSA bird's-eye view may take on new meaning thanks to new research. Scie… Read More
DNA tags enable blood-based tests to assess cancer treatment outcomesCell-free DNA (cfDNA) shed into the blood was discovered in the late 1… Read More
0 comments: